Ngu Ing Soon, Ngooi Ming Soen, Ng Han Kun, Tee Kenny Tang Long, Loo Chee Hoong, Lim Meng Shi
Department of Urology, Sarawak General Hospital, 93586, Kuching, Sarawak, Malaysia.
Department of Urology, Sarawak Heart Centre, 94300, Kota Samarahan, Sarawak, Malaysia.
Cancer Pathog Ther. 2022 Dec 10;1(1):33-39. doi: 10.1016/j.cpt.2022.12.001. eCollection 2023 Jan.
Freehand transperineal prostate biopsy (TPPBx) using a coaxial needle technique offers an alternative to probe-mounted freehand or template-guided techniques in the diagnosis of prostate cancer (PCa). It only requires the same equipment used for transrectal ultrasound-guided (TRUS) biopsy. Our study is the first in Malaysia to report this experience and its outcomes. We aim to determine PCa detection rate and pain tolerability of freehand TPPBx utilizing a coaxial needle under local anesthesia (LA).
Institutional review board approval was obtained from National Medical Research Register (NMRR ID-21-02052-VIL). We retrospectively reviewed the medical records of patients who underwent TPPBx between August 2020 and April 2022. Records were reviewed for patients' characteristics, prostate volume, prostate-specific antigen (PSA) results, biopsy results and pain tolerability. Data was analyzed to determine PCa and clinically significant prostate cancer (csPCa) detection rate. LA was achieved using perineal skin infiltration and a periprostatic nerve block. The commonly used standard side-firing transrectal ultrasound with its Prostate Biplane Transducer was used as an imaging guide. The principles of the Ginsburg protocol were followed. Pain tolerability was assessed using a visual analog scale.
A total of 55 patients with elevated PSA levels underwent freehand TPPBx under LA. The mean age was 67.3 years, the median PSA was 14.2 ng/mL, and the median PSA density (PSAD) was 0.33 ng/mL/cc. The optimal PSAD cutoff for predicting csPCa was 0.35 ng/mL/cc (area under the curve [AUC], 0.792; sensitivity, 87.5%; specificity, 69.2%). PCa was detected in 24 patients (43.6%), of whom 16 (29.1%) had csPCa. The median pain scores during LA infiltration and biopsy were four and two, respectively, which were significant different ( < 0.05). TPPBx exhibited an infection rate of zero.
The PCa detection rate and patient tolerability of freehand TPPBx using a coaxial needle are similar to those of a contemporary published series. The use of existing equipment that is used for TRUS biopsy allows for widespread use and transition from TRUS biopsy.
使用同轴针技术的徒手经会阴前列腺穿刺活检(TPPBx)为前列腺癌(PCa)诊断中探头式徒手或模板引导技术提供了一种替代方法。它仅需要用于经直肠超声引导(TRUS)活检的相同设备。我们的研究是马来西亚首个报告此经验及其结果的研究。我们旨在确定在局部麻醉(LA)下使用同轴针进行徒手TPPBx的PCa检出率和疼痛耐受性。
获得了国家医学研究注册处(NMRR ID-21-02052-VIL)的机构审查委员会批准。我们回顾性审查了2020年8月至2022年4月期间接受TPPBx的患者的病历。审查了患者的特征、前列腺体积、前列腺特异性抗原(PSA)结果、活检结果和疼痛耐受性。分析数据以确定PCa和临床显著性前列腺癌(csPCa)的检出率。通过会阴皮肤浸润和前列腺周围神经阻滞实现局部麻醉。使用常用的标准侧射式经直肠超声及其前列腺双平面探头作为成像引导。遵循金斯堡方案的原则。使用视觉模拟量表评估疼痛耐受性。
共有55例PSA水平升高的患者在局部麻醉下接受了徒手TPPBx。平均年龄为67.3岁,中位PSA为14.2 ng/mL,中位PSA密度(PSAD)为0.33 ng/mL/cc。预测csPCa的最佳PSAD临界值为0.35 ng/mL/cc(曲线下面积[AUC],0.792;敏感性,87.5%;特异性,69.2%)。24例患者(43.6%)检测到PCa,其中16例(29.1%)患有csPCa。局部麻醉浸润和活检期间的中位疼痛评分分别为4分和2分,差异有统计学意义(<0.05)。TPPBx显示感染率为零。
使用同轴针进行徒手TPPBx的PCa检出率和患者耐受性与当代已发表系列相似。使用用于TRUS活检的现有设备允许广泛使用并从TRUS活检过渡。